We use cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our cookie policy. Learn more here.Close Me
Amid conflicting agency regulations, contract manufacturers of
device components and finished devices may be subject to the new
medical device excise tax. The Health Care and Education
Reconciliation Act (Act), part of the March 2010 healthcare reform
legislation, imposed a 2.3 percent excise tax on the sale of any
"taxable medical device." However, the definition of
"taxable medical device" remains unclear. Under the Act,
a "taxable medical device" is defined according to
Section 201(h) of the Federal Food, Drug and Cosmetic Act (FFDCA),
but specifically excludes products generally purchased by the
public at retail outlets for individual use. The general
understanding was that the tax applied to manufacturers, producers
and importing manufacturers, but would not apply to contract
manufacturers of device components and finished products.
The IRS attempted to clarify the definition of a "taxable
medical device" in its proposed regulations by narrowing
Section 201(h)'s applicability to Section 510(j) of the FFDCA
and specific FDA regulations (21 CFR 807 et seq.). However, a
recent amendment to the relevant FDA regulations may broaden the
definition of "taxable medical device" to apply to
contract manufacturers of device components and finished devices.
Beginning Oct. 1, 2012, contract manufacturers of device components
and finished devices must list with the FDA the devices they
manufacture. This amendment broadens the range of manufacturers
needing to list their products with the FDA. Crucially, this
amendment would include contract manufactures and device components
under the IRS's proposed definition of a "taxable medical
device."
Until the release of the IRS's final regulations, expected
at the end of 2012, contract manufacturers of device components and
finalized devices should consult with professionals on tax and FDA
regulatory matters to discuss specifically how they are impacted by
the medical device tax.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
To print this article, all you need is to be registered on Mondaq.com.
Click to Login as an existing user or Register so you can print this article.
Whether you are an employer that provides health insurance for your employees, a business in the growing healthcare industry, a hospital, or other medical provider—or you provide services to any of those entities—you need to know about changes to the privacy and security rules under the Health Insurance Portability and Accountability Act of 1996 (HIPAA).
Understanding the complexities of the Health Insurance Portability and Accountability Act of 1996 (HIPAA) Privacy and Security Rules is often a challenge for health care providers and consumers.
Marilyn Tavenner received bipartisan support from members of the Senate Committee on Finance in her confirmation hearing to lead the Centers for Medicare and Medicaid Services (CMS) though a full Senate vote is being held up, the president released his FY 2014 budget proposal with health care reform and specified reimbursement reductions to providers and manufacturers totaling $400 billion over 10 years sprinkled throughout it, and Department of Health and Human Services (HHS) Secretary Sebelius
The Office of Inspector General for the Department of Health and Human Services has recently issued an updated Special Advisory Bulletin on the Effect of Exclusion from Participation in Federal Health Care Programs.
On Tuesday, the North Carolina legislature has enacted into law, pending the governor's signature, a prohibition on the use of most favored nations clauses in contracts between commercial health insurers and providers.
